Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Bruno Nervi, John F. DiPersio, Matthew Holt et al.|Blood|2008Cited by 481
In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemiaJaebok Choi, John F. DiPersio, Julie Ritchey et al.|Blood|2010Cited by 306